Piedmont Investment Advisors’s Quest Diagnostics DGX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q2
Sell
-2,582
Closed -$207K 181
2020
Q1
$207K Buy
2,582
+54
+2% +$5.59K 0.01% 724
2019
Q4
$270K Buy
2,528
+423
+20% +$44.1K 0.01% 798
2019
Q3
$225K Buy
2,105
+117
+6% +$12K 0.01% 835
2019
Q2
$202K Buy
+1,988
New +$191K 0.01% 906
2018
Q4
Sell
-7,075
Closed -$763K 1054
2018
Q3
$763K Sell
7,075
-808
-10% -$88.6K 0.03% 371
2018
Q2
$867K Buy
7,883
+963
+14% +$100K 0.04% 325
2018
Q1
$694K Buy
6,920
+54
+0.8% +$5.53K 0.02% 346
2017
Q4
$676K Sell
6,866
-25,365
-79% -$2.4M 0.01% 344
2017
Q3
$3.02M Sell
32,231
-6,144
-16% -$652K 0.06% 221
2017
Q2
$4.27M Sell
38,375
-29,588
-44% -$3.13M 0.09% 210
2017
Q1
$6.67M Buy
67,963
+7,843
+13% +$748K 0.14% 183
2016
Q4
$5.53M Buy
60,120
+2,290
+4% +$197K 0.11% 194
2016
Q3
$4.89M Hold
57,830
0.11% 206
2016
Q2
$4.71M Buy
57,830
+2,724
+5% +$207K 0.1% 209
2016
Q1
$3.94M Sell
55,106
-996
-2% -$66.8K 0.08% 205
2015
Q4
$3.99M Buy
56,102
+1,580
+3% +$106K 0.08% 206
2015
Q3
$3.35M Hold
54,522
0.08% 218
2015
Q2
$3.95M Buy
54,522
+122
+0.2% +$9.01K 0.08% 220
2015
Q1
$4.18M Sell
54,400
-12,578
-19% -$901K 0.26% 77
2014
Q4
$4.49M Hold
66,978
0.27% 73
2014
Q3
$4.06M Hold
66,978
0.21% 73
2014
Q2
$3.93M Buy
+66,978
New +$3.92M 0.21% 71

Other funds holding DGX

Piedmont Investment Advisors's DGX Position: Q2 2020 in Review

Piedmont Investment Advisors sold out of Quest Diagnostics (DGX) in Q2 2020, closing a stake of 2,582 shares — an estimated $207K sold.

Piedmont Investment Advisors first reported a position in DGX in Q2 2014 and held it in 22 quarters. The position peaked at $6.67M in Q1 2017. 749 funds tracked by Wall St. Rank hold DGX as of Q2 2020.

  • Piedmont Investment Advisors reported no remaining Quest Diagnostics position as of Q2 2020 after selling out during the quarter.
  • Piedmont Investment Advisors sold 2,582 Quest Diagnostics shares in Q2 2020, an estimated $207K.
  • Piedmont Investment Advisors first reported a position in Quest Diagnostics in Q2 2014 and held it in 22 quarters.
  • Piedmont Investment Advisors's Quest Diagnostics position peaked at $6.67M in Q1 2017.
  • 749 funds tracked by Wall St. Rank held Quest Diagnostics as of Q2 2020.

Based on Piedmont Investment Advisors's 13F filing for Q2 2020.